Related Experiment Video
Updated: Jun 15, 2026

A High-throughput Platform for the Screening of Salmonella spp./Shigella spp.
Published on: November 7, 2018
The disease pyramid for acute gastrointestinal illness in New Zealand
R J Lake1, S B Adlam, S Perera
1Food Safety Programme, Institute of Environmental Science and Research Ltd, Christchurch, New Zealand. rob.lake@esr.cri.nz)
Abstract:
The disease pyramid of under-ascertainment for surveillance of acute gastrointestinal illness (AGI) in New Zealand has been estimated using 2005-2007 data on notifiable diseases, a community telephone survey, and a survey of diagnostic laboratories. For each notified case of AGI there were an estimated 222 cases in the community, about 49 of which visited a general practitioner. Faecal samples were requested from about 15 of these cases, and 13 samples were provided. Of the faecal samples, pathogens were detected in about three cases. These ratios are similar to those reported in other developed countries, and provide baseline measurements of the AGI burden in the New Zealand community.
Related Concept Videos
Giardiasis
Amebiasis
Acute Pyelonephritis I: Introduction
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents
Gastritis II: Pathophysiology
Stages of Infection
